indazoles has been researched along with Hemoglobinuria, Paroxysmal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, RA; Browett, P; Geffner, M; Huang, M; Kulasekararaj, AG; Lee, JW; Maciejewski, JP; Notaro, R; Risitano, AM | 1 |
1 trial(s) available for indazoles and Hemoglobinuria, Paroxysmal
| Article | Year |
|---|---|
Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab.
Topics: Adult; Aged; Aminopyridines; Antibodies, Monoclonal, Humanized; Complement Inactivating Agents; Female; Hemoglobinuria, Paroxysmal; Humans; Indazoles; Male; Middle Aged; Proline; Pyrimidines; Treatment Outcome; Young Adult | 2021 |